Imaging of medullary thyroid carcinoma and hyperfunctioning adrenal medulla using iodine-131 metaiodobenzylguanidine.
Scintigraphy with radiolabeled metaiodobenzylguanidine was performed in a patient with MEN Type IIa having a pheochromocytoma of the right adrenal gland, adrenomedullary hyperplasia of the left adrenal gland and a primary medullary thyroid carcinoma. The scintigraphic findings demonstrate visualization of all the above mentioned pathologies.
D019797:3-Iodobenzylguanidine; D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000000981:diagnostic imaging*; D000311:Adrenal Glands / Q000000981:diagnostic imaging / Q000473:pathology; D000308:Adrenocortical Hyperfunction / Q000150:complications / Q000000981:diagnostic imaging*; D000328:Adult; D002277:Carcinoma / Q000150:complications / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000000981:diagnostic imaging; D007462:Iodobenzenes; D009377:Multiple Endocrine Neoplasia / Q000000981:diagnostic imaging*; D010673:Pheochromocytoma / Q000150:complications / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D013964:Thyroid Neoplasms / Q000150:complications / Q000000981:diagnostic imaging*
D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine